CSI Market
Sign In | Register

Chemomab Therapeutics Ltd (CMMB) Annual Balance Sheets

Annual · GAAP · USD millions
Access CMMB quarterly Balance Sheets →
Looking at balance sheet data from Chemomab Therapeutics Ltd through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.56
Deposits Assets, Current AS2.80
Cash & Short-term Investments9.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.06
Total Current Assets13.43
Equipment/Property/Plant Net0.31
Long-term investments0.00
Tax Assets, Noncurrent3.27
Prepaid Expense, Noncurrent, Total PR0.21
Other Assets, Noncurrent0.00
Restricted Cash Current-
Operating Lease Right Of Use Asset-
Total Assets13.81
Liabilities
Accounts Payable, Trade, Current0.49
Accrued Liabilities, Current0.34
Total Current Liabilities1.48
Total Long-term Debt0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities1.48
Stockholders' Equity
Treasury Stock Value0.00
Additional Paid In Capital Common Stock123.95
Retained Earnings / Accumulated Deficit-111.62
Other Equity0.00
Common Stockholder's Equity12.33
Total Stockholder's Equity12.33
Liabilities & Stockholder's Equity13.81
4 historic quarters locked

Sign in to unlock the full Chemomab Therapeutics Ltd balance sheet history.

Sign In Create Free Account

About Chemomab Therapeutics Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 23, 2026
  • Source: zk2634510.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-001593

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License